+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Sepsis Diagnostics Market by Technology (Microbiology, PCR, Microarray, Immunoassay, Biomarkers), Product (Reagents, Assay, Instruments, Software), Method, Test Type (Lab, POC), Pathogen (Bacterial, Fungal), End User and Region - Global Forecast to 2025

  • ID: 5028746
  • Report
  • May 2020
  • Region: Global
  • 200 Pages
  • Markets and Markets
1 of 6
The Global Sepsis Diagnostics Market is Projected to Grow at a CAGR of 8.5% During the Forecast Period

FEATURED COMPANIES

  • Abbott
  • Axis-Shield Diagnostics
  • Bruker Corporation
  • EKF Diagnostics
  • Luminex
  • Seegene
  • MORE

The global sepsis diagnostics market size is expected to reach USD 700 million by 2025 from USD 429 million in 2019, at a CAGR of 8.5%. The demand is expected to grow due to the rising incidence of sepsis, a growing number of surgical procedures, high incidence of hospital-acquired infections, and increasing availability of a wide variety of sepsis diagnostic devices. The sepsis diagnostics industry is segmented on the technology, product, method, pathogen, test type, end user, and region.

The blood culture segment accounted for the largest share of the sepsis diagnostics industry, by end-user, in 2019.

Based on end-users, the sepsis diagnostics market is segmented into blood culture, immunoassays, molecular diagnostics, flow cytometry, microfluidics, and biomarkers. In 2019, blood culture accounted for the largest share of the market due to the increasing incidences of sepsis coupled with the growing adoption of blood culture techniques for the diagnosis of sepsis.

The blood culture media segment accounted for the largest share of the sepsis diagnostics market, by product, in 2019.

The market, by product, is segmented into blood culture media, assays & reagents, instruments, and software. In 2019, the blood culture media segment accounted for the largest share of the sepsis diagnostics industry due to the usage of blood culture testing as the standard diagnostic method for the diagnosis and identification of sepsis across the globe.

North America accounted for the largest share of the sepsis diagnostics market in 2019.

North America accounted for the largest share of the global market in 2019, followed by Europe. This can primarily be attributed to the extensive availability of advanced sepsis diagnostic technologies, well-established distribution channels, and significant public awareness about the clinical benefits of diagnostic products in risk assessment for infectious diseases.

Breakdown of supply-side primary interviews:

  • By Company Type: Tier 1 (48%), Tier 2 (36%), and Tier 3 (16%)
  • By Designation: C-level (10%), Director-level (14%), and Others (76%)
  • By Region: North America (40%), Europe (32%), APAC (20%), and RoW (8%)

Some of the prominent players in the sepsis diagnostics market are bioMérieux (France), Becton Dickinson Company (US), Danaher (US), Abbott Laboratories (US), Roche Diagnostics (Switzerland), T2 Biosystems (US), Luminex (US), Thermo Fisher Scientific (US), Bruker (US), EKF Diagnostics (UK), Immunexpress (Australia), Response Biomedical (Canada), Axis-Shield Diagnostics (UK), and CytoSorbents (US).

Research Coverage

This report studies the sepsis diagnostics market based on technology, product, method, pathogen, test type, end-user, and region. It studies significant factors (such as drivers and restraints) affecting the market growth. The report also analyzes opportunities and challenges in the market for stakeholders. It provides details of the competitive landscape for market leaders with respect to their growth trends, prospects, and contributions to the total market. The report forecasts the revenue of market segments with respect to five major regions and their respective major countries.

Key Benefits of Buying the Report

This report focuses on various levels of analysis - industry trends, market shares of top players, and company profiles, which together form basic views. It also analyzes the competitive landscape users emerging segments of the sepsis diagnostics market; and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • Abbott
  • Axis-Shield Diagnostics
  • Bruker Corporation
  • EKF Diagnostics
  • Luminex
  • Seegene
  • MORE

1 Introduction  
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency Used for the Study
1.5 Stakeholders

2 Research Methodology  
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Secondary Sources
2.1.2 Primary Data
2.2 Market Estimation Methodology
2.2.1 Revenue Mapping-Based Market Estimation
2.2.2 Procedure-Based Market Estimation
2.2.3 Primary Research Validation
2.3 Data Triangulation
2.4 Research Assumptions
2.5 Research Limitations

3 Executive Summary  

4 Premium Insights  
4.1 Sepsis Diagnostics: Market Overview
4.2 Sepsis Diagnostics Market, by Technology
4.3 Geographic Analysis: Sepsis Diagnostics Market, by Product and Region
4.4 APAC: Sepsis Diagnostics Market, by Country and End-user
4.5 Sepsis Diagnostics Market, by Pathogen
4.6 Geographic Snapshot of the Sepsis Diagnostics Market

5 Market Overview  
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 High Incidence of Sepsis
5.2.1.2 Rising Incidence of Hospital-Acquired Infections
5.2.1.3 Growing Funding for Sepsis-Related Research
5.2.2 Restraints
5.2.2.1 Unfavorable Reimbursement Scenario
5.2.2.2 High Cost of Automated Diagnostic Devices
5.2.3 Opportunities
5.2.3.1 Development of Rapid Diagnostic/Poc Techniques for Early Sepsis Diagnosis
5.2.3.2 Evolution of Novel Biomarkers for Sepsis Diagnosis
5.2.4 Challenges
5.2.4.1 Lack of Standard Protocols and Awareness
5.2.4.2 Shortage of Skilled Healthcare Professionals

6 Sepsis Diagnostics Market, by Technology  
6.1 Introduction
6.2 Blood Culture
6.2.1 Blood Culture Holds the Largest Share of the Technology Market
6.3 Immunoassays
6.3.1 Product Development Efforts by Major Players Have Ensured Demand for Immunoassays
6.4 Molecular Diagnostics
6.4.1 Polymerase Chain Reaction
6.4.1.1 Pcr Holds the Largest Share of the Molecular Diagnostics Market
6.4.2 Microarrays
6.4.2.1 Simultaneous Analysis Capabilities, Accuracy, and Rapidity Have Driven the Use of Microarrays
6.4.3 Peptide Nucleic Acid-Fluorescent in Situ Hybridization
6.4.3.1 PNA-Fish Kits Allow for the Rapid Diagnosis of BSIS
6.4.4 Syndromic Panel-Based Testing
6.4.4.1 High Costs and Accuracy Issues Have Affected Test Adoption
6.5 Flow Cytometry
6.5.1 Lack of Standardized Protocols is a Key Restraint in this Market Segment
6.6 Microfluidics
6.6.1 Growing Adoption of Advanced & Rapid Testing Will Favor Market Growth in this Segment
6.7 Biomarkers
6.7.1 Despite Potential, No Single Ideal Biomarker Has Been Identified for Sepsis Diagnostics

7 Sepsis Diagnostics Market, by Product  
7.1 Introduction
7.2 Blood Culture Media
7.2.1 Blood Culture Media Dominate the Products Market
7.3 Assays & Reagents
7.3.1 Increasing Awareness Has Driven the Use of Assays & Reagents
7.4 Instruments
7.4.1 Market is Characterized by a Shift from Traditional & Manual Instruments to Automated Systems
7.5 Software
7.5.1 Rising Use of Automated Instruments Will Ensure Demand for Software

8 Sepsis Diagnostics Market, by Method  
8.1 Introduction
8.2 Conventional Diagnostics
8.2.1 Conventional Diagnostics Holds Largest Market Share
8.3 Automated Diagnostics
8.3.1 Automated Diagnostics Segment to Grow at the Highest Cagr

9 Sepsis Diagnostics Market, by Pathogen  
9.1 Introduction
9.2 Bacterial Sepsis
9.2.1 Gram-Negative Bacterial Sepsis
9.2.1.1 Gram-Negative Bacteria Cause ~50% of Sepsis Infections
9.2.2 Gram-Positive Bacterial Sepsis
9.2.2.1 Cases of Sepsis Caused by Gram-Positive Bacteria Have Risen in Recent Years
9.3 Fungal Sepsis
9.3.1 Fungemia is the Second-Biggest Cause of Bloodstream Infections
9.4 Other Pathogens

10 Sepsis Diagnostics Market, by Test Type  
10.1 Introduction
10.2 Laboratory Tests
10.2.1 Laboratory Tests Are the Most Common and Preferred Mode of Testing
10.3 Point-Of-Care Tests
10.3.1 Rapidity and Convenience Have Driven Demand for Poc Tests

11 Sepsis Diagnostics Market, by End-user  
11.1 Introduction
11.2 Hospitals
11.2.1 Hospitals Hold the Largest Share of the Sepsis Diagnostics Market
11.3 Pathology & Reference Laboratories
11.3.1 Independent Laboratories Offer Affordability as Well as the Benefits of Bundled Services
11.4 Research Laboratories & Academic Institutes
11.4.1 Government Support and Rising Awareness Have Ensured Demand for Market Products in this Segment

12 Sepsis Diagnostics Market, by Region  
12.1 Introduction
12.2 North America
12.2.1 US
12.2.1.1 Us is the Largest Market for Sepsis Diagnostics
12.2.2 Canada
12.2.2.1 Growing Availability of Sepsis Diagnostic Products to Support Market Growth in Canada
12.3 Europe
12.3.1 Germany
12.3.1.1 Germany Accounted for the Largest Share of the European Market
12.3.2 France
12.3.2.1 High Incidence and Rising Awareness Have Supported the Demand for Sepsis Diagnostics in France
12.3.3 UK
12.3.3.1 Government Support and Rising Awareness Are Key Drivers in the UK
12.3.4 Italy
12.3.4.1 Sluggish Growth in the Italian Healthcare Sector in the Last Few Years to Restrain the Market Growth
12.3.5 Spain
12.3.5.1 Rising Sepsis Incidence to Drive Market Growth in Spain
12.3.6 Rest of Europe
12.4 Asia-Pacific
12.4.1 Japan
12.4.1.1 Significant Growth in Pneumonia and Infectious Disease Incidence to Support Market Growth in Japan
12.4.2 China
12.4.2.1 Healthcare Infrastructure Improvements to Support Market Growth in China
12.4.3 India
12.4.3.1 Increasing Patient Population and Rising Number of Surgical Procedures Are Key Growth Drivers in India
12.4.4 Australia
12.4.4.1 Increasing Number of Sepsis Treatment Procedures Indicates Growth Potential in the Australian Market
12.4.5 South Korea
12.4.5.1 Rising Healthcare Spending Supports Market Growth in South Korea
12.4.6 Rest of Asia-Pacific
12.5 Latin America
12.5.1 Brazil
12.5.1.1 Brazil Accounted for the Largest Share of the Latam Market
12.5.2 Mexico
12.5.2.1 Rising Medical Tourism to Support Market Growth in Mexico
12.5.3 Rest of Latin America
12.6 Middle East & Africa
12.6.1 High Consumption of Immune System-Suppressing Medications is Driving Sepsis Occurrence

13 Competitive Landscape  
13.1 Overview
13.2 Market Share Analysis
13.3 Competitive Scenario
13.3.1 Product Launches and Approvals, 2016–2020
13.3.2 Partnerships and Collaborations, 2016–2020
13.3.3 Mergers and Acquisitions, 2016–2020
13.3.4 Market Expansion, 2016–2020
13.4 Competitive Leadership Mapping
13.4.1 Visionary Leaders
13.4.2 Innovators
13.4.3 Dynamic Differentiators
13.4.4 Emerging Companies

14 Company Profiles  
14.1 Biomérieux
14.2 Becton, Dickinson and Company
14.3 Danaher
14.4 T2 Biosystems
14.5 Luminex
14.6 Roche Diagnostics
14.7 Thermo Fisher Scientific
14.8 Bruker Corporation
14.9 Abbott
14.10 Immunexpress
14.11 Response Biomedical
14.12 Axis-Shield Diagnostics
14.13 Cytosorbents
14.14 Mitsubishi Chemical Europe
14.15 EKF Diagnostics
14.16 Emerging Players
14.16.1 Seegene
14.16.2 Genmark Diagnostics
14.16.3 Boditech Med
14.16.4 Alpha Laboratories
14.16.5 Alifax S.R.L.

15 Appendix  
15.1 Discussion Guide
15.2 Knowledge Store
15.3 Available Customizations
15.4 Related Reports
15.5 Author Details

List of Tables (160 Tables)
Table 1 Sepsis Diagnostics Market, by Technology, 2017–2025 (Usd Million)
Table 2 Blood Culture Market for Sepsis Diagnostics, by Region, 2017–2025 (Usd Million)
Table 3 Blood Culture Market for Sepsis Diagnostics, by Product, 2017–2025 (Usd Million)
Table 4 Blood Culture Market for Sepsis Diagnostics, by Method, 2017–2025 (Usd Million)
Table 5 Blood Culture Market for Sepsis Diagnostics, by Pathogen, 2017–2025 (Usd Million)
Table 6 Blood Culture Market for Sepsis Diagnostics, by Test Type, 2017–2025 (Usd Million)
Table 7 Blood Culture Market for Sepsis Diagnostics, by End-user, 2017–2025 (Usd Million)
Table 8 Immunoassays Market for Sepsis Diagnostics, by Region, 2017–2025 (Usd Million)
Table 9 Immunoassays Market for Sepsis Diagnostics, by Product, 2017–2025 (Usd Million)
Table 10 Immunoassays Market for Sepsis Diagnostics, by Method, 2017–2025 (Usd Million)
Table 11 Immunoassays Market for Sepsis Diagnostics, by Pathogen, 2017–2025 (Usd Million)
Table 12 Immunoassays Market for Sepsis Diagnostics, by Test Type, 2017–2025 (Usd Million)
Table 13 Immunoassays Market for Sepsis Diagnostics, by End-user, 2017–2025 (Usd Million)
Table 14 Molecular Diagnostics Market for Sepsis Diagnostics, by Technique, 2017–2025 (Usd Million)
Table 15 Molecular Diagnostics Market for Sepsis Diagnostics, by Region, 2017–2025 (Usd Million)
Table 16 Molecular Diagnostics Market for Sepsis Diagnostics, by Product, 2017–2025 (Usd Million)
Table 17 Molecular Diagnostics Market for Sepsis Diagnostics, by Method, 2017–2025 (Usd Million)
Table 18 Molecular Diagnostics Market for Sepsis Diagnostics, by Pathogen, 2017–2025 (Usd Million)
Table 19 Molecular Diagnostics Market for Sepsis Diagnostics, by Test Type, 2017–2025 (Usd Million)
Table 20 Molecular Diagnostics Market for Sepsis Diagnostics, by End-user, 2017–2025 (Usd Million)
Table 21 Pcr Market for Sepsis Diagnostics, by Region, 2017–2025 (Usd Million)
Table 22 Pcr Market for Sepsis Diagnostics, by Product, 2017–2025 (Usd Million)
Table 23 Pcr Market for Sepsis Diagnostics, by Method, 2017–2025 (Usd Million)
Table 24 Pcr Market for Sepsis Diagnostics, by Pathogen, 2017–2025 (Usd Million)
Table 25 Pcr Market for Sepsis Diagnostics, by Test Type, 2017–2025 (Usd Million)
Table 26 Pcr Market for Sepsis Diagnostics, by End-user, 2017–2025 (Usd Million)
Table 27 Microarrays Market for Sepsis Diagnostics, by Region, 2017–2025 (Usd Million)
Table 28 Microarrays Market for Sepsis Diagnostics, by Product, 2017–2025 (Usd Million)
Table 29 Microarrays Market for Sepsis Diagnostics, by Method, 2017–2025 (Usd Million)
Table 30 Microarrays Market for Sepsis Diagnostics, by Pathogen, 2017–2025 (Usd Million)
Table 31 Microarrays Market for Sepsis Diagnostics, by Test Type, 2017–2025 (Usd Million)
Table 32 Microarrays Market for Sepsis Diagnostics, by End-user, 2017–2025 (Usd Million)
Table 33 PNA-Fish Market for Sepsis Diagnostics, by Region, 2017–2025 (Usd Million)
Table 34 PNA-Fish Market for Sepsis Diagnostics, by Product, 2017–2025 (Usd Million)
Table 35 PNA-Fish Market for Sepsis Diagnostics, by Method, 2017–2025 (Usd Million)
Table 36 PNA-Fish Market for Sepsis Diagnostics, by Pathogen, 2017–2025 (Usd Million)
Table 37 PNA-Fish Market for Sepsis Diagnostics, by Test Type, 2017–2025 (Usd Million)
Table 38 PNA-Fish Market for Sepsis Diagnostics, by End-user, 2017–2025 (Usd Million)
Table 39 Syndromic Panel-Based Testing Market for Sepsis Diagnostics, by Region, 2017–2025 (Usd Million)
Table 40 Syndromic Panel-Based Testing Market for Sepsis Diagnostics, by Product, 2017–2025 (Usd Million)
Table 41 Syndromic Panel-Based Testing Market for Sepsis Diagnostics, by Method, 2017–2025 (Usd Million)
Table 42 Syndromic Panel-Based Testing Market for Sepsis Diagnostics, by Pathogen, 2017–2025 (Usd Million)
Table 43 Syndromic Panel-Based Testing Market for Sepsis Diagnostics, by Test Type, 2017–2025 (Usd Million)
Table 44 Syndromic Panel-Based Testing Market for Sepsis Diagnostics, by End-user, 2017–2025 (Usd Million)
Table 45 Flow Cytometry Market for Sepsis Diagnostics, by Region, 2017–2025 (Usd Million)
Table 46 Flow Cytometry Market for Sepsis Diagnostics, by Product, 2017–2025 (Usd Million)
Table 47 Flow Cytometry Market for Sepsis Diagnostics, by Method, 2017–2025 (Usd Million)
Table 48 Flow Cytometry Market for Sepsis Diagnostics, by Pathogen, 2017–2025 (Usd Million)
Table 49 Flow Cytometry Market for Sepsis Diagnostics, by Test Type, 2017–2025 (Usd Million)
Table 50 Flow Cytometry Market for Sepsis Diagnostics, by End-user, 2017–2025 (Usd Million)
Table 51 Microfluidics Market for Sepsis Diagnostics, by Region, 2017–2025 (Usd Million)
Table 52 Microfluidics Market for Sepsis Diagnostics, by Product, 2017–2025 (Usd Million)
Table 53 Microfluidics Market for Sepsis Diagnostics, by Method, 2017–2025 (Usd Million)
Table 54 Microfluidics Market for Sepsis Diagnostics, by Pathogen, 2017–2025 (Usd Million)
Table 55 Microfluidics Market for Sepsis Diagnostics, by Test Type, 2017–2025 (Usd Million)
Table 56 Microfluidics Market for Sepsis Diagnosis, by End-user, 2017 – 2025 (Usd Million)
Table 57 Biomarkers Market for Sepsis Diagnostics, by Region, 2017–2025 (Usd Million)
Table 58 Biomarkers Market for Sepsis Diagnostics, by Product, 2017–2025 (Usd Million)
Table 59 Biomarkers Market for Sepsis Diagnostics, by Method, 2017–2025 (Usd Million)
Table 60 Biomarkers Market for Sepsis Diagnostics, by Pathogen, 2017–2025 (Usd Million)
Table 61 Biomarkers Market for Sepsis Diagnostics, by Test Type, 2017–2025 (Usd Million)
Table 62 Biomarkers Market for Sepsis Diagnostics, by End-user, 2017–2025 (Usd Million)
Table 63 Sepsis Diagnostics Market, by Product, 2017–2025 (Usd Million)
Table 64 Sepsis Diagnostic Blood Culture Media Market, by Region, 2017–2025 (Usd Million)
Table 65 Sepsis Diagnostic Assays & Reagents Market, by Region, 2017–2025 (Usd Million)
Table 66 Sepsis Diagnostic Instruments Market, by Region, 2017–2025 (Usd Million)
Table 67 Sepsis Diagnostic Software Market, by Region, 2017–2025 (Usd Million)
Table 68 Sepsis Diagnostics Market, by Method, 2017–2025 (Usd Million)
Table 69 Conventional Diagnostics Market, by Region, 2017–2025 (Usd Million)
Table 70 Automated Diagnostics Market, by Region, 2017–2025 (Usd Million)
Table 71 Sepsis Diagnostics Market, by Pathogen, 2017–2025 (Usd Million)
Table 72 Bacterial Sepsis Market, by Type, 2017–2025 (Usd Million)
Table 73 Bacterial Sepsis Market, by Region, 2019–2025 (Usd Million)
Table 74 Causes of Adult Sepsis: Gram-Negative Bacteria
Table 75 Gram-Negative Bacterial Sepsis Market, by Region, 2019–2025 (Usd Million)
Table 76 Causes of Adult Sepsis: Gram-Positive Bacteria
Table 77 Gram-Positive Bacterial Sepsis Market, by Region, 2019–2025 (Usd Million)
Table 78 Fungal Sepsis Market, by Region, 2019–2025 (Usd Million)
Table 79 Other Pathogens Market, by Region, 2017–2025 (Usd Million)
Table 80 Sepsis Diagnostics Market, by Test Type, 2017–2025 (Usd Million)
Table 81 Laboratory Sepsis Diagnostic Tests Market, by Region, 2017–2025 (Usd Million)
Table 82 Point-Of-Care Sepsis Diagnostic Tests Market, by Region, 2017–2025 (Usd Million)
Table 83 Sepsis Diagnostics Market, by End-user, 2017–2025 (Usd Million)
Table 84 Sepsis Diagnostics Market for Hospitals, by Region, 2017–2025 (Usd Million)
Table 85 Sepsis Diagnostics Market for Pathology & Reference Laboratories, by Region, 2017–2025 (Usd Million)
Table 86 Sepsis Diagnostics Market for Research Laboratories & Academic Institutes, by Region, 2017–2025 (Usd Million)
Table 87 Sepsis Diagnostics Market, by Region, 2017–2025 (Usd Million)
Table 88 North America: Sepsis Diagnostics Market, by Country, 2017–2025 (Usd Million)
Table 89 North America: Sepsis Diagnostics Market, by Technology, 2017–2025 (Usd Million)
Table 90 North America: Molecular Diagnostics Market for Sepsis Diagnostics, by Technique, 2017–2025 (Usd Million)
Table 91 North America: Sepsis Diagnostics Market, by Product, 2017–2025 (Usd Million)
Table 92 North America: Sepsis Diagnostics Market, by Pathogen, 2017–2025 (Usd Million)
Table 93 North America: Sepsis Diagnostics Market, by Method, 2017–2025 (Usd Million)
Table 94 North America: Sepsis Diagnostics Market, by Test Type, 2017–2025 (Usd Million)
Table 95 North America: Sepsis Diagnostics Market, by End-user, 2017–2025 (Usd Million)
Table 96 Us: Sepsis Diagnostics Market, by Technology, 2017–2025 (Usd Million)
Table 97 Us: Molecular Diagnostics Market for Sepsis Diagnostics, by Technique, 2017–2025 (Usd Million)
Table 98 Canada: Sepsis Diagnostics Market, by Technology, 2017–2025 (Usd Million)
Table 99 Canada: Molecular Diagnostics Market for Sepsis Diagnostics, by Technique, 2017–2025 (Usd Million)
Table 100 Europe: Sepsis Diagnostics Market, by Country, 2017–2025 (Usd Million)
Table 101 Europe: Sepsis Diagnostics Market, by Technology, 2017–2025 (Usd Million)
Table 102 Europe: Molecular Diagnostics Market for Sepsis Diagnostics, by Technique, 2017–2025 (Usd Million)
Table 103 Europe: Sepsis Diagnostics Market, by Product, 2017–2025 (Usd Million)
Table 104 Europe: Sepsis Diagnostics Market, by Pathogen, 2017–2025 (Usd Million)
Table 105 Europe: Sepsis Diagnostics Market, by Method, 2017–2025 (Usd Million)
Table 106 Europe: Sepsis Diagnostics Market, by Test Type, 2017–2025 (Usd Million)
Table 107 Europe: Sepsis Diagnostics Market, by End-user, 2017–2025 (Usd Million)
Table 108 Germany: Sepsis Diagnostics Market, by Technology, 2017–2025 (Usd Million)
Table 109 Germany: Molecular Diagnostics Market for Sepsis Diagnostics, by Technique, 2017–2025 (Usd Million)
Table 110 France: Sepsis Diagnostics Market, by Technology, 2017–2025 (Usd Million)
Table 111 France: Molecular Diagnostics Market for Sepsis Diagnostics, by Technique, 2017–2025 (Usd Million)
Table 112 Uk: Sepsis Diagnostics Market, by Technology, 2017–2025 (Usd Million)
Table 113 Uk: Molecular Diagnostics Market for Sepsis Diagnostics, by Technique, 2017–2025 (Usd Million)
Table 114 Italy: Sepsis Diagnostics Market, by Technology, 2017–2025 (Usd Million)
Table 115 Italy: Molecular Diagnostics Market for Sepsis Diagnostics, by Technique, 2017–2025 (Usd Million)
Table 116 Spain: Sepsis Diagnostics Market, by Technology, 2017–2025 (Usd Million)
Table 117 Spain: Molecular Diagnostics Market for Sepsis Diagnostics, by Technique, 2017–2025 (Usd Million)
Table 118 Rest of Europe: Sepsis Diagnostics Market, by Technology, 2017–2025 (Usd Million)
Table 119 Rest of Europe: Molecular Diagnostics Market for Sepsis Diagnostics, by Technique, 2017–2025 (Usd Million)
Table 120 Asia-Pacific: Sepsis Diagnostics Market, by Country, 2017–2025 (Usd Million)
Table 121 Asia-Pacific: Sepsis Diagnostics Market, by Technology, 2017–2025 (Usd Million)
Table 122 Asia-Pacific: Molecular Diagnostics Market for Sepsis Diagnostics, by Technique, 2017–2025 (Usd Million)
Table 123 Asia-Pacific: Sepsis Diagnostics Market, by Product, 2017–2025 (Usd Million)
Table 124 Asia-Pacific: Sepsis Diagnostics Market, by Pathogen, 2017–2025 (Usd Million)
Table 125 Asia-Pacific: Sepsis Diagnostics Market, by Method, 2017–2025 (Usd Million)
Table 126 Asia-Pacific: Sepsis Diagnostics Market, by Test Type, 2017–2025 (Usd Million)
Table 127 Asia-Pacific: Sepsis Diagnostics Market, by End-user, 2017–2025 (Usd Million)
Table 128 Japan: Sepsis Diagnostics Market, by Technology, 2017–2025 (Usd Million)
Table 129 Japan: Molecular Diagnostics Market for Sepsis Diagnostics, by Technique, 2017–2025 (Usd Million)
Table 130 China: Sepsis Diagnostics Market, by Technology, 2017–2025 (Usd Million)
Table 131 China: Molecular Diagnostics Market for Sepsis Diagnostics, by Technique, 2017–2025 (Usd Million)
Table 132 India: Sepsis Diagnostics Market, by Technology, 2017–2025 (Usd Million)
Table 133 India: Molecular Diagnostics Market for Sepsis Diagnostics, by Technique, 2017–2025 (Usd Million)
Table 134 Australia: Sepsis Diagnostics Market, by Technology, 2017–2025 (Usd Million)
Table 135 Australia: Molecular Diagnostics Market for Sepsis Diagnostics, by Technique, 2017–2025 (Usd Million)
Table 136 South Korea: Sepsis Diagnostics Market, by Technology, 2017–2025 (Usd Million)
Table 137 South Korea: Molecular Diagnostics Market for Sepsis Diagnostics, by Technique, 2017–2025 (Usd Million)
Table 138 Rest of Asia-Pacific: Sepsis Diagnostics Market, by Technology, 2017–2025 (Usd Million)
Table 139 Rest of Asia-Pacific: Molecular Diagnostics Market for Sepsis Diagnostics, by Technique, 2017–2025 (Usd Million)
Table 140 Latin America: Sepsis Diagnostics Market, by Country, 2017–2025 (Usd Million)
Table 141 Latin America: Sepsis Diagnostics Market, by Technology, 2017–2025 (Usd Million)
Table 142 Latin America: Molecular Diagnostics Market for Sepsis Diagnostics, by Technique, 2017–2025 (Usd Million)
Table 143 Latin America: Sepsis Diagnostics Market, by Product, 2017–2025 (Usd Million)
Table 144 Latin America: Sepsis Diagnostics Market, by Pathogen, 2017–2025 (Usd Million)
Table 145 Latin America: Sepsis Diagnostics Market, by Method, 2017–2025 (Usd Million)
Table 146 Latin America: Sepsis Diagnostics Market, by Test Type, 2017–2025 (Usd Million)
Table 147 Latin America: Sepsis Diagnostics Market, by End-user, 2017–2025 (Usd Million)
Table 148 Brazil: Sepsis Diagnostics Market, by Technology, 2017–2025 (Usd Million)
Table 149 Brazil: Molecular Diagnostics Market for Sepsis Diagnostics, by Technique, 2017–2025 (Usd Million)
Table 150 Mexico: Sepsis Diagnostics Market, by Technology, 2017–2025 (Usd Million)
Table 151 Mexico: Molecular Diagnostics Market for Sepsis Diagnostics, by Technique, 2017–2025 (Usd Million)
Table 152 Rest of Latin America: Sepsis Diagnostics Market, by Technology, 2017–2025 (Usd Million)
Table 153 Rest of Latin America: Molecular Diagnostics Market for Sepsis Diagnostics, by Technique, 2017–2025 (Usd Million)
Table 154 Middle East and Africa: Sepsis Diagnostics Market, by Technology, 2017–2025 (Usd Million)
Table 155 Middle East and Africa: Molecular Diagnostics Market for Sepsis Diagnostics, by Technique, 2017–2025 (Usd Million)
Table 156 Middle East and Africa: Sepsis Diagnostics Market, by Product, 2017–2025 (Usd Million)
Table 157 Middle East and Africa: Sepsis Diagnostics Market, by Pathogen, 2017–2025 (Usd Million)
Table 158 Middle East and Africa: Sepsis Diagnostics Market, by Method, 2017–2025 (Usd Million)
Table 159 Middle East and Africa: Sepsis Diagnostics Market, by Test Type, 2017–2025 (Usd Million)
Table 160 Middle East and Africa: Sepsis Diagnostics Market, by End-user, 2017–2025 (Usd Million)

List of Figures (36 Figures)
Figure 1 Research Design
Figure 2 Breakdown of Primaries: Global Sepsis Diagnostics Market
Figure 3 Research Methodology: Hypothesis Building
Figure 4 Market Size Estimation: Sepsis Diagnostics Market
Figure 5 Data Triangulation Methodology
Figure 6 Sepsis Diagnostics Market, by Product, 2019 Vs 2025
Figure 7 Sepsis Diagnostics Market, by Technology, 2019 Vs 2025
Figure 8 Sepsis Diagnostics Market, by Method, 2019 Vs 2025
Figure 9 Sepsis Diagnostics Market, by Test Type, 2019 Vs 2025
Figure 10 Sepsis Diagnostics Market, by Pathogen, 2019 Vs 2025
Figure 11 Sepsis Diagnostics Market, by End-user, 2018
Figure 12 Global Sepsis Diagnostics Market, by Region, 2019 (Usd Million)
Figure 13 Rising Prevalence of Sepsis is Driving Demand for Diagnostics
Figure 14 Blood Culture Segment Will Dominate the Market During 2019–2025
Figure 15 Blood Culture Media Segment to Dominate the Global Sepsis Diagnostics Products Market in 2019
Figure 16 Hospitals Segment to Dominate the Asia-Pacific Market During the Forecast Period
Figure 17 Gram-Negative Bacterial Sepsis Holds Largest Share of the Global Market, by Pathogen
Figure 18 Asia-Pacific to Register the Highest CAGR During the Forecast Period
Figure 19 Sepsis Diagnostics Market: Drivers, Restraints, Opportunities, and Challenges
Figure 20 North America: Sepsis Diagnostics Market Snapshot
Figure 21 APAC: Sepsis Diagnostics Market Snapshot
Figure 22 Key Developments by Leading Market Players in the Sepsis Diagnostics Market, 2016–2019
Figure 23 Sepsis Diagnostics Market Share, by Key Players, 2018
Figure 24 Sepsis Diagnostics Market (Global) Competitive Leadership Mapping, 2019
Figure 25 Biomérieux: Company Snapshot
Figure 26 BD: Company Snapshot
Figure 27 Danaher: Company Snapshot
Figure 28 T2 Biosystems: Company Snapshot (2019)
Figure 29 Luminex: Company Snapshot
Figure 30 Roche Diagnostics: Company Snapshot
Figure 31 Thermo Fisher Scientific: Company Snapshot
Figure 32 Bruker: Company Snapshot
Figure 33 Abbott: Company Snapshot
Figure 34 Cytosorbents: Company Snapshot
Figure 35 Mitsubishi Chemical Europe: Company Snapshot
Figure 36 EKF Diagnostics: Company Snapshot

Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6
5 of 6
  • Abbott
  • Alifax S.R.L.
  • Alpha Laboratories
  • Axis-Shield Diagnostics
  • Becton, Dickinson and Company
  • Biomérieux
  • Boditech Med
  • Bruker Corporation
  • Cytosorbents
  • Danaher
  • EKF Diagnostics
  • Genmark Diagnostics
  • Immunexpress
  • Luminex
  • Mitsubishi Chemical Europe
  • Response Biomedical
  • Roche Diagnostics
  • Seegene
  • T2 Biosystems
  • Thermo Fisher Scientific
Note: Product cover images may vary from those shown
6 of 6

Loading
LOADING...

Adroll
adroll